Loading...
NPI 1235570334 · Little Rock, AR · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kavanaughrx LLC is a community/retail pharmacy provider located in Little Rock, Arkansas. This profile covers 12 Medicare and 16 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Kavanaughrx LLC |
| Address | 5200 Kavanaugh Blvd |
| City | Little Rock |
| State | AR |
| ZIP | 72207 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | July 17, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $186.7K |
| Medicaid | $49.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 490 | $130 | $63.2K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 350 | $70 | $25.5K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 640 | $40 | $23.8K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 150 | $140 | $21.3K |
| G0008 | Administration of influenza virus vaccine | 560 | $30 | $15.6K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 180 | $80 | $13.8K |
| 0124A | N/A | 230 | $40 | $8.5K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 500 | $10 | $6K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $280 | $5.3K |
| 0134A | N/A | 80 | $40 | $2.9K |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
12 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 53 | 290 | 240 | $10 | $17.4K |
| 91322 | 49 | 380 | 70 | $140 | $12.9K |
| 91320 | 3 | 280 | 50 | $130 | $10.6K |
| 90677 | 330 | 570 | 20 | $280 | $7.8K |
| 90694 | 44 | 410 | 60 | $70 | $6.5K |
| 90662 | 12 | 870 | 50 | $70 | $5.7K |
| 90480 | 3 | 560 | 80 | $30 | $3.2K |
| G0008 | 13 | 1,340 | 60 | $30 | $2.5K |
| 0124A | 1 | 140 | 20 | $40 | $1.2K |
| 90686 | 84 | 120 | 20 | $20 | $1.1K |
Showing 1–10 of 12
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0002A | N/A | 590 | $30 | $17.7K |
| 0001A | N/A | 670 | $20 | $12.7K |
| 0071A | N/A | 100 | $90 | $9.4K |
| 0072A | N/A | 70 | $100 | $6.2K |
| 0003A | N/A | 70 | $30 | $2.1K |
| 0031A | N/A | 80 | $10 | $780 |
| 0124A | N/A | 20 | $30 | $560 |
| 0064A | N/A | 30 | $10 | $190 |
| 0004A | N/A | 30 | $0 | $0 |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 20 | $0 | $0 |
Showing 1–10 of 16
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
16 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 0002A | N/A | 16 | 320 | 60 | $30 | $5.9K |
| 0001A | N/A | 18 | 350 | 70 | $30 | $5.5K |
| 0072A | N/A | 29 | 110 | 30 | $70 | $5.4K |
| 0071A | N/A | 22 | 140 | 40 | $70 | $5.4K |
| 0124A | N/A | 16 | 30 | 20 | $40 | $3.4K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 16 | 20 | 30 | $40 | $3.4K |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 86 | 110 | 60 | $10 | $1.9K |
| 0031A | N/A | 6 | 50 | 20 | $20 | $1.3K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 24 | 30 | 30 | $10 | $770 |
| 0003A | N/A | 10 | 50 | 30 | $10 | $680 |
Showing 1–10 of 16
Other providers in the same ZIP code as Kavanaughrx LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Mct, Inc. | AR | In Home Supportive Care Agency | $0 | $3.6M |
| Arkansas Pathology Associates PA | AR | Anatomic Pathology & Clinical Pathology Physician | $683.2K | $864.4K |
| Endoscopy Center Of Arkansas, LLC | AR | Ambulatory Surgical Clinic/Center | $527.6K | $30.6K |
| Stephen Tilley | AR | Family Medicine Physician | $225.2K | $0 |
| Katherine Steward | AR | Anatomic Pathology & Clinical Pathology Physician | $68.1K | $103.5K |
| David Pope | AR | Anatomic Pathology & Clinical Pathology Physician | $102.5K | $14.6K |
| Paul Stout | AR | Anatomic Pathology & Clinical Pathology Physician | $97.2K | $2.7K |
| Silpa Maram | AR | Internal Medicine Physician | $88.1K | $0 |
| Kristin Dishongh | AR | Anatomic Pathology & Clinical Pathology Physician | $67.3K | $8.2K |
| Sally Browder | AR | Clinical Psychologist | $63.2K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.